EP4642448A1 — A method for the treatment of epilepsy
Assigned to Indian Institute of Science IISC · Expires 2025-11-05 · 1y expired
What this patent protects
The present disclosure provides a method for the treatment of epilepsy syndrome and/or seizure in a subject, by administering a therapeutically effective amount of the compound or salt thereof as disclosed herein. Embodiments herein further overcome the challenges that are genera…
USPTO Abstract
The present disclosure provides a method for the treatment of epilepsy syndrome and/or seizure in a subject, by administering a therapeutically effective amount of the compound or salt thereof as disclosed herein. Embodiments herein further overcome the challenges that are generally observed with the use of existing anti- epileptic drugs, such as poor patient response, severe physical and/or psychological side effects and prevalence of drug resistance, etc. Accordingly, the present disclosure provides a compound for use in treating epilepsy syndrome and/or seizure. Also disclosed herein is a composition for the treatment of epilepsy syndrome and/or seizure.
Drugs covered by this patent
- Ztalmy (GANAXOLONE) · Marinus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.